Prescribed Renoprotective Chinese Herbal Medicines Were Associated with a Lower Risk of All-Cause and Disease-Specific Mortality among Patients with Chronic Kidney Disease: A Population-Based Follow-Up Study in Taiwan

Association of prescribed Chinese herbal medicine use with risk of end-stage renal disease in patients with chronic kidney disease

(2015) Ming-Yen Lin et al.   KIDNEY INTERNATIONAL

Integrating traditional Chinese medicine healthcare into diabetes care by reducing the risk of developing kidney failure among type 2 diabetic patients: A population-based case control study

(2014) Pei-Chien Hsu et al.   JOURNAL OF ETHNOPHARMACOLOGY

Non-aristolochic acid prescribed Chinese herbal medicines and the risk of mortality in patients with chronic kidney disease: results from a population-based follow-up study

(2014) Chuan Fa Hsieh et al.   BMJ Open

Effects of natural phytochemicals inAngelica sinensis(Danggui) on Nrf2-mediated gene expression of phase II drug metabolizing enzymes and anti-inflammation

(2013) Constance Lay Lay Saw et al.   BIOPHARMACEUTICS & DRUG DISPOSITION

Therapeutic use of traditional Chinese herbal medications for chronic kidney diseases

(2013) Yifei Zhong et al.   KIDNEY INTERNATIONAL

Increased risk of chronic kidney disease among users of non-prescribed Chinese herbal medicine in Taiwan

(2012) Chuan-Fa Hsieh et al.   PREVENTIVE MEDICINE

Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy

(2011) LQ Meng et al.   BRITISH JOURNAL OF PHARMACOLOGY

Effects of salivae miltiorrhizae liguspyragine hydrochloride and glucose injection (参芎葡萄糖注射液) on the levels of main platelet thrombin receptors in chronic haemodialysis patients

(2011) Yan Li et al.   Chinese Journal of Integrative Medicine

Astragalus polysaccharide injection integrated with vinorelbine and cisplatin for patients with advanced non-small cell lung cancer: effects on quality of life and survival

(2011) Li Guo et al.   MEDICAL ONCOLOGY

Risks of Kidney Failure Associated With Consumption of Herbal Products Containing Mu Tong or Fangchi: A Population-Based Case-Control Study

(2010) Ming-Nan Lai et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Chronic Kidney Disease in the Urban Poor

(2010) Y. N. Hall et al.   Clinical Journal of the American Society of Nephrology

Analgesic use and the risk for progression of chronic kidney disease

(2010) Hsin-Wei Kuo et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Using the Pharmacoepidemiology Approach to Evaluate the First-Year Posttransplantation Ambulatory Health Care Cost From the Longitudinal Health Insurance Database (2001 to 2006) in Taiwan

(2010) E.K.-L. Lee et al.   TRANSPLANTATION PROCEEDINGS

Population-Based Case-Control Study of Chinese Herbal Products Containing Aristolochic Acid and Urinary Tract Cancer Risk

(2009) M.-N. Lai et al.   JNCI-Journal of the National Cancer Institute

Racial and Ethnic Differences in Trends of End-Stage Renal Disease: United States, 1995 to 2005

(2008) Nilka Ríos Burrows et al.   ADVANCES IN CHRONIC KIDNEY DISEASE

The analysis of Radix Angelicae Sinensis (Danggui)

(2008) Lunzhao Yi et al.   JOURNAL OF CHROMATOGRAPHY A

Nephro-protective effect of Kangqianling decoction on chronic renal failure rats

(2008) Liqun He et al.   JOURNAL OF ETHNOPHARMACOLOGY

The Secret of Immortal Time Bias in Epidemiologic Studies

(2008) S. Z. Shariff et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan

(2008) Chi Pang Wen et al.   LANCET

Increased risks of chronic kidney disease associated with prescribed Chinese herbal products suspected to contain aristolochic acid

(2008) MING-NAN LAI et al.   NEPHROLOGY